83 results on '"Chen, Jersey"'
Search Results
2. Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis
3. Evaluation of methodologies for indirect comparison of eplontersen and vutrisiran for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy (P12-4.005)
4. Living with heart failure: patient experiences and implications for physical activity and daily living
5. Post-Hospitalization Care of Patients with Acute Coronary Syndrome
6. Risk of Vascular Toxicity with Platinum Based Chemotherapy in Elderly Patients with Bladder Cancer
7. Stress Testing Before Low-Risk Surgery
8. National trends in stroke after acute myocardial infarction among Medicare patients in the United States: 1999 to 2010
9. Approaches to Enhancing Radiation Safety in Cardiovascular Imaging
10. Assessment of the 12-Lead ECG as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12–25 Years of Age)
11. Assessment of the 12-Lead Electrocardiogram as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12–25 Years of Age)
12. National Trends in Recurrent AMI Hospitalizations 1 Year After Acute Myocardial Infarction in Medicare Beneficiaries: 1999–2010
13. Abstract 107: Cardiovascular Events, Early Discontinuation of Trastuzumab, and Their Impact on Survival
14. Abstract 280: Cardiologist Consultation and Associated Outcomes for Older Women with Heart Failure after Breast Cancer Therapy
15. Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival
16. UPTAKE OF NOVEL ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR AND VALVULAR ATRIAL FIBRILLATION: RESULTS FROM THE NCDR-PINNACLE REGISTRY
17. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease
18. Risk Prediction Model for Heart Failure and Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
19. National Trends in Heart Failure Hospitalization After Acute Myocardial Infarction for Medicare Beneficiaries
20. Determinants of fluoroscopy time for invasive coronary angiography and percutaneous coronary intervention: Insights from the NCDR®
21. Abstract 39: Does Higher Use Of Non-invasive Testing Improve the Diagnostic Yield Of Coronary Angiography?
22. Abstract 223: National and Regional Trends in Hospitalizations for Hemorrhagic Stroke after Acute Myocardial Infarction in the United States: 1999-2010
23. Abstract 221: National and Regional Trends in Hospitalizations for Ischemic Stroke after Acute Myocardial Infarction in the United States: 1999-2010
24. National Trends in Heart Failure Hospital Stay Rates, 2001 to 2009
25. Relationship Between Hospital Readmission and Mortality Rates for Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia
26. Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
27. Abstract 18979: Early Termination of Adjuvant Trastuzumab Associated with Cardiovascular Events in Older Women with Breast Cancer
28. Development of 2 Registry-Based Risk Models Suitable for Characterizing Hospital Performance on 30-Day All-Cause Mortality Rates Among Patients Undergoing Percutaneous Coronary Intervention
29. Based On Key Measures, Care Quality For Medicare Enrollees At Safety-Net And Non-Safety-Net Hospitals Was Almost Equal
30. Recent Trends in Hospitalization for Acute Myocardial Infarction
31. Abstract 134: Stress MPI is the Most Frequent Index Cardiac Diagnostic Test for a Commercially Insured Population
32. Age-Related Macular Degeneration and Incident Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis
33. RISK OF HEART FAILURE OR CARDIOMYOPATHY ASSOCIATED WITH ADJUVANT TRASTUZUMAB OR CHEMOTHERAPY IN OLDER WOMEN WITH BREAST CANCER
34. Skilled Nursing Facility Referral and Hospital Readmission Rates after Heart Failure or Myocardial Infarction
35. Use and Effectiveness of Intra-Aortic Balloon Pumps Among Patients Undergoing High Risk Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry
36. Abstract 8656: Age-Related Macular Degeneration and Incident Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis
37. Abstract P14: Increased Prescription of Dual Antiplatelet Therapy Following CHARISMA and ACTIVE-W
38. National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008
39. Reply
40. Do Imaging Studies Performed in Physician Offices Increase Downstream Utilization?
41. Use of Medical Imaging Procedures With Ionizing Radiation in Children
42. RECENT TRENDS IN HOSPITALIZATION RATES FOR ACUTE MYOCARDIAL INFARCTION
43. Economic Evaluation of Clopidogrel Plus Aspirin for Secondary Prevention of Cardiovascular Events in Canada for Patients With Established Cardiovascular Disease: Results From the CHARISMA Trial
44. Cumulative Exposure to Ionizing Radiation From Diagnostic and Therapeutic Cardiac Imaging Procedures
45. Hospital Volume and 30-Day Mortality for Three Common Medical Conditions
46. Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries
47. Differences in Patient Survival After Acute Myocardial Infarction by Hospital Capability of Performing Percutaneous Coronary Intervention
48. CUMULATIVE EXPOSURE TO IONIZING RADIATION FROM CARDIAC IMAGING PROCEDURES
49. DEVELOPMENT OF TWO REGISTRY-BASED MEASURES SUITABLE FOR CHARACTERIZING HOSPITAL PERFORMANCE ON 30-DAY ALL-CAUSE MORTALITY RATES AMONG PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
50. Thirty-Day Outcomes in Medicare Patients With Heart Failure at Heart Transplant Centers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.